Clinical Trial Update: A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 [Phase 2]

View source ↗

Summary

Phase 2 trial update for autologous heat shock protein gp96 immunotherapy in glioma of the brain (glioblastoma context not explicitly stated in snippet).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme
• Glioma of the Brain

Drugs mentioned

• gp96 autologous heat shock protein (heat shock protein gp96)

Snippet

Sponsor: Cure&Sure Biotech Co., LTD | Conditions: Glioma of Brain | Phase 2 | Status: UNKNOWN